Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Novartis Investigative Site, Vienna

Novartis Investigative Site, Berlin

Novartis Investigative Site, Berlin

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Lübeck

Novartis Investigative Site, Kiel

Novartis Investigative Site, Brest

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Grenoble

Novartis Investigative Site, Nantes

Novartis Investigative Site, Essen

Novartis Investigative Site, Münster

Novartis Investigative Site, Cologne

Novartis Investigative Site, Frankfurt am Main

Novartis Investigative Site, Homburg

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Paris

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigative Site, Erlangen

Novartis Investigative Site, Regensburg

Novartis Investigative Site, Würzburg

Novartis Investigative Site, Innsbruck

Novartis Investigative Site, Linz

Novartis Investigative Site, Leipzig